Simple, Direct and Stability-Indicating UV Spectrophotometric Assay of Pioglitazone Hydrochloride in Pharmaceuticals

Authors

  • N. Rajendraprasad
  • K. Basavaiah

DOI:

https://doi.org/10.37591/(rrjops).v8i3.13

Abstract

Pioglitazone hydrochloride (PGH) is an antihyperglycemic agent used in the treatment of type-2 diabetes mellitus. A simple and straight forward UV-spectrophotometric method is presented for the determination of PGH in bulk drug and tablets by measuring the absorbance of drug solution in 0.1M H2SO4 at 269 nm. A plot of absorbance versus concentration obeyed Beer’s law over 2–36 µg ml-1 concentration range (r = 0.9981) with a molar absorptivity of 8.85 × 103 l mol-1 cm-1. The limits of detection (LOD) and quantification (LOQ) were calculated to be 0.65 and 1.98 µg ml-1, respectively. Intraday accuracy and precision, expressed as %RE and %RSD, were upto 2.0 and upto1.45, respectively; whereas the respective interday values were upto 2.05 and upto 1.36. The method was validated for robustness and ruggedness as well as selectivity. The method, when applied to the determination of the active ingredient in tablets, yielded percent found values of 98.69±1.18 and 101.2±1.25 for two brands of tablets. Accuracy of the method was checked by recovery study via standard addition procedure, and found to be highly satisfactory. To determine the stability-indicating ability of the developed method, the drug was subjected to acid-, alkali-, peroxide-, heat- and light-induced forced degradation, and determined subsequently by the recommended procedure. Results indicated that the drug was vulnerable to alkali-induced stress condition, but remained intact under other stress conditions.

Keywords: Pioglitazone, determination, UV-spectrophotometry, pharmaceuticals, stabilityindicating

Cite this Article Rajendraprasad N, Basavaiah K. Simple, Direct and Stability-indicating UV Spectrophotometric Assay of Pioglitazone Hydrochloride in Pharmaceuticals. Research & Reviews: A Journal of Pharmaceutical Science. 2017; 8(3): 7–16p. 

Downloads

Published

2017-12-04

Issue

Vol. 8 No. 3 (2017)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.